Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-00556

First experience with the MitraClip XTR device for extensive mitral valve prolapse (Barlow’s disease)

Karolina Weinmann, MD; Sinisa Markovic, MD; Wolfgang Rottbauer, MD; Mirjam Keßler*, MD

Figure 1. Transoesophageal echocardiography before and after MitraClip implantation. A) Before MitraClip implantation. B) After MitraClip implantation. * Structural defect. AML: anterior mitral leaflet; Ao: aortic valve; PML: posterior mitral leaflet

Various surgical strategies exist for Barlow’s disease (extensive mitral valve prolapse >1 segment, leaflet thickening)1. However, interventional therapy using the MitraClip® (Abbott Vascular, Santa Clara, CA, USA) in high-risk surgical candidates with Barlow’s disease is complex: either highly mobile leaflets lead to relevant residual mitral regurgitation (MR) or extensive grasping of redundant leaflet tissue might result in mitral stenosis2. In 2018 the MitraClip NTR and XTR (both Abbott Vascular) were launched, featuring technical modifications of the delivery catheter (shaft extension increased by 1.5 cm, more direct, predictable trajectory during positioning) and lock mechanism. In the MitraClip XTR, arm length has been increased from 9 mm to 12 mm and coaptation length and grasping is facilitated by two additional rows of frictional elements at the grippers. So far, the MitraClip XTR has been employed predominantly in functional MR and severely impaired left ventricular function3.

We used the MitraClip XTR in four patients with Barlow’s disease because of its increased coaptation length facilitating grasping of redundant tissue of prolapsing segments. All patients had severe MR (effective regurgitant orifice area of 0.6-2.2 cm2) with prolapse of >1 segment (6-13 mm above the annulus) (Figure 1A). The left atria were enlarged concomitant with severe MR, easing device positioning. Mitral annulus dilatation was not a prerequisite for the MitraClip XTR. By deployment of the MitraClip XTR at the main prolapse site, leaflet mobility was stabilised. Significant reduction to mild MR was achieved in one patient. In the other patients, a second MitraClip (NTR or XTR, depending on the length of the remaining leaflets) was placed at the centre of the remaining regurgitation to stabilise the leaflets further; this achieved sufficient MR reduction. No relevant transmitral gradients (mean pressure gradient 2-6 mmHg) occurred, even after implantation of a second MitraClip (Figure 1B).

Interventional treatment of Barlow’s disease is challenging due to the high mobility of the mitral leaflets; however, the latest MitraClip XTR renders the beneficial use of MitraClip devices possible.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 14 Number 12
Dec 20, 2018
Volume 14 Number 12
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I5A115 Sep 22, 2015
Unintentional sealing of the mitral valve with a second MitraClip. “Once bitten, twice shy”
Alipour A et al
free

Expert review

10.4244/EIJ-D-20-00883 Nov 20, 2020
Percutaneous mitral valve leaflet repair: ongoing directions and future perspectives
Maisano F and Taramasso M
free

10.4244/EIJV9I5A102 Sep 27, 2013
MitraClip® via direct right atrial access in case of a missing inferior vena cava
Frerker C et al
free

10.4244/EIJV11SWA11 Sep 17, 2015
The MitraClip transcatheter mitral valve repair system
Grasso C and Baldus S
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA14 Sep 18, 2016
The MitraClip system: strategies for optimal patient selection and optimised results
Grasso C and Ince H
free

10.4244/EIJV8SQA10 Sep 30, 2012
Transcatheter mitral valve interventions: current status and future perspective
Feldman T and Ali O
free

10.4244/EIJV11SWA10 Sep 17, 2015
Transcatheter mitral valve repair: a brief review
Barbanti M et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00511 Sep 7, 2018
Transcatheter mitral valve repair: review of the clinical evidence
Taramasso M et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY14M07_05 Jul 20, 2015
MitraClip repair of a “trileaflet” regurgitant mitral valve
Freixa X et al
free

10.4244/EIJV11SWA14 Sep 17, 2015
Transcatheter direct mitral valve annuloplasty: a brief review
Feldman T and Guerrero M
free
Trending articles
318.3

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.85

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
72.15

State-of-the-art

10.4244/EIJ-D-22-00627 Feb 6, 2023
Left atrial appendage occlusion
Holmes D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
49.55

CLINICAL RESEARCH

10.4244/EIJ-D-17-00962 Apr 6, 2018
A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
Fujino A et al
free
42.95

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved